Fig. 1
- ID
- ZDB-FIG-180807-25
- Publication
- Sztal et al., 2018 - Testing of therapies in a novel nebulin nemaline myopathy model demonstrate a lack of efficacy
- Other Figures
- All Figure Page
- Back to All Figure Page
Characterization of the neb (sa906) mutant zebrafish strain. a & b) At 4 dpf neb?/? zebrafish (aii) appear smaller in size and (bii) display a loss of birefringence compared to their wildtype siblings (ai & bi). c) RT-PCR analysis in and neb?/? mutant embryos at 2 dpf shows a reduction in neb mRNA levels compared to wildtype siblings (sibling). ?Act was used as a positive control. d) ii) neb?/? mutants display a smaller eye, brain region (B) and deflated swim bladder (SB) compared to their i) wildtype siblings. e) Quantification of the maximum acceleration recorded from touch-evoked response assays of neb?/? fish compared to wildtype siblings at 2 dpf. Error bars represent meanħSEM for three independent experiments (n =?11,9,12 neb ?/? , 55,25,32 neb +/? , 18,13,12 neb +/+ zebrafish per experiment), **p <?0.01. f & g) Quantification of the normalized (f) distance and (g) speed travelled by neb?/? mutants compared to wildtype siblings at 6 dpf. For f) error bars represent medianħinterquartile range for three independent experiments (for n =?19,23,19 neb ?/? , 41,42,36 neb +/? , 31,20,21 neb +/+ zebrafish). For g) error bars represent meanħSEM range (for n?=?19,23,14 neb ?/? , 41,42,36 neb +/? , 30,20,21 neb +/+ zebrafish per experiment). *p <?0.5, **** p <?0.001 |
Fish: | |
---|---|
Observed In: | |
Stage Range: | Long-pec to Day 6 |